Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families

Genes and Immunity

Volumn 9, Issue 2, 2008, Pages 153-160

  Rhodes, B ^a   Wong, A ^a   Navarra, S V ^b   Villamin, C ^b   Vyse, T J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SANTO TOMAS   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FAMILY STUDY; FEMALE; FILIPINO; GENE EXPRESSION; GENE FREQUENCY; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENOTYPE; HAPLOTYPE; HERITABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; POPULATION GENETICS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RELATIVE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; PHILIPPINES; RISK FACTORS;

EID: 40549091381     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364459     Document Type: Article

References (41)

1. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-1812.
2. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-1397.
3. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
4. Lange LA, Burdon K, Langefeld CD, Liu Y, Beck SR, Rich SS et al. Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Ann Hum Genet 2006; 70: 717-725.
5. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH et al. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 2001; 154: 681-689.
6. Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W et al. C-reactive protein, an 'intermediate phenotype' for inflammation: Human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J Hypertens 2007; 25: 329-343.
7. Austin MA, Zhang C, Humphries SE, Chandler WL, Talmud PJ, Edwards KL, et al. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 2004; 68: 179-188.
8. Chang MK, Binder CJ, Torzewski M, Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 2002; 99: 13043-13048.
9. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42: 23-30.
10. Volanakis JE. Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389: 235-250.
11. Pereira Da Silva JA, Elkon KB, Hughes GR, Dyck RF, Pepys MB. C-reactive protein levels in systemic lupus erythematosus: A classification criterion? Arthritis Rheum 1980; 23: 770-771.
12. Toloza SM, Uribe AG, McGwin Jr G, Alarcon GS, Fessler BJ, Bastian HM et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947-3957.
13. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M et al Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005; 77 64-77.
14. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney Jr JF et al Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006; 113: 1415-1423.
15. Miller DT, Zee RY, Suk DJ, Kozlowski P, Chasman DI, Lazarus R et al Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005; 69: 623-638.
16. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13: 137-147.
17. Judson R, Brain C, Dain B, Windemuth A, Ruano G, Reed C. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 2004; 177: 345-351.
18. Latkovskis G, Licis N, Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 2004; 31: 207-213.
19. Marz W, Scharnagl H, Hoffmann MM, Boehm BO, Winkelmann BR. The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). Eur Heart J 2004; 25: 2109-2119.
20. Paik JK, Kim OY, Koh SJ, Jong Y, Chae JS, Kim JY et al. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors. Clin Chim Acta 2007; 380: 68-74.
21. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M et al Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034.
22. Chasman DI, Kozlowski P, Zee RY, Kwiatkowski DJ, Ridker PM. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes Immun 2006; 7 211-219.
23. Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002; 17: 171-174.
24. Eklund C, Lehtimaki T, Hurme M. Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 2005; 32: 229-232.
25. Shin KK, Jang Y, Koh SJ, Chae JS, Kim OY, Park S et al. Influence of the IL-6 -572C>G polymorphism on inflammatory markers according to cigarette smoking in Korean healthy men. Cytokine 2007; 39: 116-122.
26. Williams Jr RC, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol 2005; 32: 454-461.
27. Jonsen A, Gunnarsson I, Gullstrand B, Svenungsson E, Bengtsson AA, Nived O et al. Association between SLE nephritis and polymorphic variants of the CCRP and FcgammaRIIIa genes. Rheumatology (Oxford) 2007; 46: 1417-1421.
28. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M et al Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006; 114: 2458-2465.
29. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular evertis. JAMA 2006; 296: 2703-2711.
30. Suk HJ, Ridker PM, Cook NR, Zee RY, Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 2005; 178: 139-145.
31. Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, Williams A et al Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 2005; 83: 440-447.
32. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
33. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
34. Nei M, Roychoudhury AK. Evolutionary relationships of human populations on a global scale. Mol Biol Evol 1993; 10: 927-943.
35. Ross P, Hall L, Smirnov I, Haff L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998; 16: 1347-1351.
36. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
37. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
38. Clement M, Posada D, Crandall KA. TCS:. a computer program to estimate gene genealogies. Mol Ecol 2000; 9: 1657-1659.
39. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68 978-989.
40. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
41. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30; 97-101.